0.60Open0.60Pre Close0 Volume4 Open Interest10.00Strike Price0.00Turnover444.03%IV45.63%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.60Extrinsic Value100Contract SizeAmericanOptions Type-0.1024Delta0.0187Gamma28.82Leverage Ratio-0.1508Theta-0.0003Rho-2.95Eff Leverage0.0038Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet